{"id":739242,"date":"2026-07-02T16:28:16","date_gmt":"2026-07-02T16:28:16","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/739242\/"},"modified":"2026-07-02T16:28:16","modified_gmt":"2026-07-02T16:28:16","slug":"1-healthcare-stock-with-impressive-fundamentals-and-2-we-turn-down","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/739242\/","title":{"rendered":"1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down"},"content":{"rendered":"<p>    <a href=\"https:\/\/s.yimg.com\/lo\/mysterio\/api\/1EFED5E3FC12C37221F8810731BF48EECFFBAAA153F5E87BE76FC7878BEBF8B8\/subgraphmysterio\/resizefit_w960;quality_80;format_webp\/https:%2F%2Fmedia.zenfs.com%2Fen%2Fstockstory_922%2Fa25ba48e8ef069333892e091164ffc5c\" target=\"_blank\" rel=\"noopener noreferrer nofollow\"><img loading=\"lazy\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"MCK Cover Image\" height=\"480\" width=\"960\" class=\"yf-lglytj loader\"\/><\/a> 1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down           <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 16.3% over the past six months, topping the S&amp;P 500 by 7 percentage points.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Regardless of these results, investors must exercise caution as many businesses in this space are subject to heavy regulation that can influence their earnings potential. Keeping that in mind, here is one healthcare stock boasting a durable advantage and two best left ignored.  <\/p>\n<p>                 Two Healthcare Stocks to Sell:          AMN Healthcare Services (AMN)          <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Market Cap: $1.19 billion  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">With a network of thousands of healthcare professionals ranging from nurses to physicians to executives, AMN Healthcare (NYSE:AMN) provides healthcare workforce solutions including temporary staffing, permanent placement, and technology platforms for hospitals and healthcare facilities across the United States.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Why Are We Out on AMN?  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Declining travelers on assignment over the past two years show it&#8217;s struggled to increase its sales volumes and had to rely on price increases  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Falling earnings per share over the last five years has some investors worried as stock prices ultimately follow EPS over the long term  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Diminishing returns on capital suggest its earlier profit pools are drying up  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">AMN Healthcare Services&#8217;s stock price of $33.10 implies a valuation ratio of 38.4x forward P\/E. <a href=\"https:\/\/stockstory.org\/us\/stocks\/nyse\/amn?utm_source=screener&amp;utm_medium=yahoo&amp;utm_campaign=underperformScreenerCTA&amp;utm_article=Clp1a2sFZEU%3D&amp;utm_ticker=MCK\" data-ylk=\"slk:Dive%20into%20our%20free%20research%20report%20to%20see%20why%20there%20are%20better%20opportunities%20than%20AMN;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Dive into our free research report to see why there are better opportunities than AMN&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Dive into our free research report to see why there are better opportunities than AMN<\/a>.  <\/p>\n<p>            Novavax (NVAX)          <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Market Cap: $1.48 billion  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Pioneering a nanoparticle technology that mimics the molecular structure of disease pathogens, Novavax (NASDAQ:NVAX) develops and commercializes protein-based vaccines for infectious diseases, with a primary focus on its COVID-19 vaccine and combination respiratory vaccine candidates.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Why Do We Avoid NVAX?  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Annual sales declines of 22.6% for the past two years show its products and services struggled to connect with the market during this cycle  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Projected sales decline of 50.7% over the next 12 months indicates demand will continue deteriorating  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Cash-burning tendencies make us wonder if it can sustainably generate shareholder value  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">At $9.41 per share, Novavax trades at 5.2x forward price-to-sales. <a href=\"https:\/\/stockstory.org\/us\/stocks\/nasdaq\/nvax?utm_source=screener&amp;utm_medium=yahoo&amp;utm_campaign=underperformScreenerCTA&amp;utm_article=Clp1a2sFZEU%3D&amp;utm_ticker=MCK\" data-ylk=\"slk:Read%20our%20free%20research%20report%20to%20see%20why%20you%20should%20think%20twice%20about%20including%20NVAX%20in%20your%20portfolio%2C%20it&#039;s%20free;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Read our free research report to see why you should think twice about including NVAX in your portfolio, it&#039;s free&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Read our free research report to see why you should think twice about including NVAX in your portfolio, it&#8217;s free<\/a>.  <\/p>\n<p>        One Healthcare Stock to Buy:          McKesson (MCK)          <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Market Cap: $94.62 billion  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">With roots dating back to 1833, making it one of America&#8217;s oldest continuously operating businesses, McKesson (NYSE:MCK) is a healthcare services company that distributes pharmaceuticals, medical supplies, and provides technology solutions to pharmacies, hospitals, and healthcare providers.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Why Are We Bullish on MCK?  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">14.3% annual revenue growth over the last two years surpassed the sector average as its offerings resonated with customers  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Dominant market position is represented by its $403.4 billion in revenue, which creates significant barriers to entry in this highly regulated industry  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Share buybacks catapulted its annual earnings per share growth to 17.9%, which outperformed its revenue gains over the last five years  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">McKesson is trading at $766.85 per share, or 17.1x forward P\/E. Is now the right time to buy? <a href=\"https:\/\/stockstory.org\/us\/stocks\/nyse\/mck?utm_source=screener&amp;utm_medium=yahoo&amp;utm_campaign=EndResearchReport&amp;utm_article=Clp1a2sFZEU%3D&amp;utm_ticker=MCK\" data-ylk=\"slk:See%20for%20yourself%20in%20our%20comprehensive%20research%20report%2C%20it&#039;s%20free;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;See for yourself in our comprehensive research report, it&#039;s free&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">See for yourself in our comprehensive research report, it&#8217;s free<\/a>.  <\/p>\n<p>       High-Quality Stocks for All Market Conditions         <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">WHILE YOU&#8217;RE HERE: Top 9 Market-Beating Stocks. The best stocks don&#8217;t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">But our AI platform says the party isn&#8217;t over. Find out which 9 stocks made the cut this week \u2014 FREE. <a href=\"https:\/\/stockstory.org\/high-quality\/market-beating-stocks?utm_source=screener&amp;utm_medium=yahoo&amp;utm_campaign=EndCategory&amp;utm_content=20260301_top_9_market_beating&amp;utm_article=Clp1a2sFZEU%3D&amp;utm_ticker=MCK\" data-ylk=\"slk:Get%20Our%20Top%209%20Market-Beating%20Stocks%20for%20Free%20HERE;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Get Our Top 9 Market-Beating Stocks for Free HERE&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Get Our Top 9 Market-Beating Stocks for Free HERE<\/a>.  <\/p>\n<p class=\"text text-block paragraph text-left neo-font-paragraph-xl-reg  yf-18d6y07\" style=\"text-decoration: none; font-style: normal; text-transform: none; text-align: inherit; font-variant-numeric: normal;\">Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). <a href=\"https:\/\/stockstory.org\/discover\/high-quality-stocks?utm_source=screener&amp;utm_medium=yahoo&amp;utm_campaign=discover&amp;utm_article=Clp1a2sFZEU%3D&amp;utm_ticker=MCK\" data-ylk=\"slk:Find%20your%20next%20big%20winner%20with%20StockStory%20today;elm:context_link;itc:0;sec:content-canvas;source:content-canvas%20default\" data-yga=\"{&quot;yLinkText&quot;:&quot;Find your next big winner with StockStory today&quot;,&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yTrafficOrigin&quot;:&quot;content-canvas default&quot;}\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">Find your next big winner with StockStory today<\/a>.  <\/p>\n","protected":false},"excerpt":{"rendered":"1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down Personal health and wellness is one of&hellip;\n","protected":false},"author":2,"featured_media":739243,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[301289,24583,97,252,253,151893,145859,5728,317883],"class_list":["post-739242","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-amn-healthcare","tag-earnings-per-share","tag-health","tag-health-care","tag-healthcare","tag-healthcare-companies","tag-healthcare-services","tag-market-cap","tag-workforce-solutions"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/739242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=739242"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/739242\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/739243"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=739242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=739242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=739242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}